Sorafenib
Sorafenib
Sorafenib (pronounced: soh-RAF-eh-nib) is a kinase inhibitor used primarily for the treatment of certain types of cancer.
Etymology
The name "Sorafenib" is derived from the acronym of the company that first developed it, Soros Research Advanced Frontier Economic Network International Biotechnology.
Usage
Sorafenib is used to treat advanced renal cell carcinoma, a type of kidney cancer, and unresectable hepatocellular carcinoma, a type of liver cancer. It works by slowing the spread of cancer cells and cutting off the blood supply that keeps cancer cells growing.
Side Effects
Common side effects of Sorafenib include fatigue, nausea, vomiting, diarrhea, and rash. Serious side effects may include liver disease, bleeding, high blood pressure, and heart disease.
Related Terms
- Kinase inhibitor
- Cancer
- Renal cell carcinoma
- Hepatocellular carcinoma
- Liver disease
- High blood pressure
- Heart disease
External links
- Medical encyclopedia article on Sorafenib
- Wikipedia's article - Sorafenib
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski